Developmental Research Program
The Developmental Research Program in the University of Iowa/Mayo Clinic Lymphoma SPORE supports innovative and scientifically sound projects investigating any area related to translational lymphoma research.
Funding in the Developmental Research Program is provided for one or two years to support novel lymphoma research projects. The long-term goal is to translate the findings generated by developmental projects into reductions in the incidence and mortality rates of lymphoma.
The Developmental Research Program:
- Encourages innovative laboratory and translationally relevant clinical studies
- Fosters extensive collaboration between basic science and clinical disciplines in translational research in lymphoma
- Encourages investigators to evaluate the potential of applying their research findings to translational research in lymphoma
- Generates new hypotheses to be tested in large-scale research projects or clinical trials that may lead to significant reductions in lymphoma incidence and mortality rates
Developmental Research Program funds are awarded based on scientific merit, originality and relevance to the objectives of the Lymphoma SPORE.
The directors of the Developmental Research Program are:
- Steven R. Lentz, M.D., Ph.D., of the University of Iowa
- Stephen J. Russell, M.D., Ph.D., of Mayo Clinic